
Organon & Co.
(NYSE) OGN
Organon & Co. Financials at a Glance
Market Cap
$3.52B
Revenue (TTM)
$6.16B
Net Income (TTM)
$246.00M
EPS (TTM)
$0.94
P/E Ratio
14.30
Dividend
$0.08
Beta (Volatility)
0.81 (Low)
Dividend
$0.08
Beta (Volatility)
0.81 (Low)
Price
$13.46
Volume
2,420,753.638
Open
$13.43
Price
$13.46
Volume
2,420,753.638
Open
$13.43
Previous Close
$13.46
Daily Range
$13.41 - $13.48
52-Week Range
$5.69 - $13.48
Dividend
$0.08
Beta (Volatility)
0.81 (Low)
Price
$13.46
Volume
2,420,753.638
Open
$13.43
Previous Close
$13.46
Daily Range
$13.41 - $13.48
52-Week Range
$5.69 - $13.48
OGN News




OGN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Organon & Co.
Industry
Pharmaceuticals
Sector
Health CareEmployees
10,000
CEO
Joseph T. Morrissey, Jr., MBA
Website
www.organon.comHeadquarters
Jersey City, NJ 07302, US
OGN Financials
Key Financial Metrics (TTM)
Gross Margin
53%
Operating Margin
19%
Net Income Margin
4%
Return on Equity
34%
Return on Capital
11%
Return on Assets
2%
Earnings Yield
6.99%
Dividend Yield
0.60%
Payout Ratio
8.94%
Stock Overview
Market Cap
$3.52B
Shares Outstanding
262.60M
Volume
2.42M
Avg. Volume
8.95M
Financials (TTM)
Gross Profit
$3.36B
Operating Income
$1.28B
EBITDA
$1.28B
Operating Cash Flow
$700.00M
Capital Expenditure
$162.00M
Free Cash Flow
$538.00M
Cash & ST Invst.
$574.00M
Total Debt
$8.80B
Organon & Co. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.46B
-3.5%
Gross Profit
$783.00M
-6.9%
Gross Margin
53.63%
N/A
Market Cap
$3.52B
N/A
Market Cap/Employee
$352.41K
N/A
Employees
10,000
N/A
Net Income
$146.00M
+67.8%
EBITDA
$351.00M
+8.0%
Quarterly Fundamentals
Net Cash
$7.45B
+11.4%
Accounts Receivable
$1.38B
-5.7%
Inventory
$1.37B
+0.8%
Long Term Debt
$8.55B
-4.3%
Short Term Debt
$16.00M
-20.0%
Return on Assets
1.89%
N/A
Return on Invested Capital
11.29%
N/A
Free Cash Flow
$188.00M
+954.5%
Operating Cash Flow
$225.00M
+200.0%



